Misplaced Pages

Indium (111In) imciromab

Article snapshot taken from Wikipedia with creative commons attribution-sharealike license. Give it a read and then ask your questions in the chat. We can research this topic together.
(Redirected from Imciromab) Pharmaceutical compound
Indium (In) imciromab
Monoclonal antibody
TypeFab fragment
SourceMouse
Targetcardiac myosin
Clinical data
Trade namesMyoscint
ATC code
Legal status
Legal status
  • withdrawn
Identifiers
CAS Number
ChemSpider
  • none
UNII
  (what is this?)  (verify)

Indium (In) imciromab (trade name Myoscint) is a mouse monoclonal antibody labelled with the radioisotope Indium-111. It was used for cardiac imaging, but withdrawn in 1993.

See also

References

  1. WHO Drug Information
  2. "DiagnosticImaging.com: Centocor withdraws imaging agent applications". Archived from the original on 2012-02-26. Retrieved 2009-10-17.
Diagnostic radiopharmaceuticals (V09)
Central nervous system
Skeletal system
Renal
Gastrointestinal/Hepatic
Respiratory system
Cardiovascular system
Inflammation/infection
Tumor
Adrenal cortex
Radionuclides
(including tracers)
positron (PET list)
gamma ray/photon (SPECT/scintigraphy)
Isotopes used: See also: Therapeutic radiopharmaceuticals (V10)
Monoclonals for bone, musculoskeletal, circulatory, and neurologic systems
Bone
Human
Humanized
Musculoskeletal
Human
Circulatory
Human
Mouse
Chimeric
Humanized
Neurologic
Human
Humanized
Angiogenesis inhibitor
Humanized
Growth factor
Human
Humanized


Stub icon

This monoclonal antibody–related article is a stub. You can help Misplaced Pages by expanding it.

Stub icon

This nuclear medicine article is a stub. You can help Misplaced Pages by expanding it.

Categories: